Concepedia

Devraj Chakravarty

DC

Statistics

Publications

7

Citations

199

H-Index

7

Active since

2006

Affiliations

Johnson & Johnson (United States)(Current)

Janssen (United States)

Devraj Chakravarty is an author at Johnson & Johnson (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

2006–2013

7

Publications

7

In Vivo Characterization of a Dual Adenosine A<sub>2A</sub>/A<sub>1</sub> Receptor Antagonist in Animal Models of Parkinson’s Disease

Brian C. Shook, Stefanie Rassnick, Melville C. Osborne et al. · Journal of Medicinal Chemistry · 2010 · 54 citations · Full text

, , +19

Design and Characterization of Optimized Adenosine A<sub>2A</sub>/A<sub>1</sub> Receptor Antagonists for the Treatment of Parkinson's Disease

Brian C. Shook, Stefanie Rassnick, Nathaniel Wallace et al. · Journal of Medicinal Chemistry · 2012 · 46 citations · Full text

, , +12

Microwave-assisted Sonogashira-type cross couplings of various heterocyclic methylthioethers

Brian C. Shook, Devraj Chakravarty, Paul Jackson · Tetrahedron Letters · 2008 · 26 citations

, , +2

Substituted thieno[2,3-d]pyrimidines as adenosine A2A receptor antagonists

Brian C. Shook, Devraj Chakravarty, J. Kent Barbay et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 25 citations · Full text

, , +4

Methylene amine substituted arylindenopyrimidines as potent adenosine A2A/A1 antagonists

Brian C. Shook, Stefanie Rassnick, D.W.R. Hall et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 24 citations · Full text

, , +4

1–5 of 7